Modern opportunities of heart rate regulation in coronary heart disease

Modern opportunities of heart rate regulation in coronary heart disease

It has been demonstrated that high heart rate (HR) levels are an independent risk factor of cardiovascular events and mortality from coronary heart disease and chronic heart failure (CHF). Recently, the so-called If-inhibitors which selectively block the pacemaker current in sinoatrial node cells (i...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. Sh. Zagidullin, D. F. Gareeva, B. I. Zagidullin, E. O. Travnikova, R. Kh. Zulkarneev, Sh. Z. Zagidullin
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2013-10-01
Series:	Российский кардиологический журнал
Subjects:	heart rate heart failure ivabradine coronary heart disease
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/422
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HEART RATE TURBULENCE AS A MORTALITY PREDICTOR IN LONG-TERM STUDY IN PATIENTS WITH CORONARY HEART DISEASE
by: D. Gareeva, et al.
Published: (2016-04-01)

Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease
by: N. Sh. Zagidullin, et al.
Published: (2009-04-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)

Ivabradine – a new agent for coronary heart disease treatment
by: O. A. Maneshina, et al.
Published: (2006-06-01)

DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
by: M. V. Surovtseva, et al.
Published: (2012-12-01)

Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

Could heart rate be regarded as cardiovascular disease risk factor?
by: V. I. Makolkin, et al.
Published: (2006-12-01)

IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
by: S. A. Sayganov, et al.
Published: (2010-06-01)

Heart rate-lowering therapy in gout patients with stable coronary artery disease: focus on ivabradine
by: N. N. Kushnarenko, et al.
Published: (2020-08-01)

New approach to heart rate control as mortality reduction method in cardiac patients: potential of a new If inhibitor, ivabradine
by: Yu. B. Belousov, et al.
Published: (2007-12-01)

E INFLUENCE OF IF-CHANNEL INHIBITION ON HEART RATE VARIABILITY IN PATIENTS POST CORONARY BYPASS SURGERY BY THE TEST WITH FIXED RESPIRATION TEMPO
by: I. V. Kochetkova, et al.
Published: (2017-03-01)

Perindopril effects on circadian heart rate variability in patients with coronary heart disease and stable angina
by: N. A. Shardanov, et al.
Published: (2007-08-01)

Heart rate variability and hemostatic parameters in patients with coronary heart disease and chronic heart failure
by: M. Z. Buy, et al.
Published: (2013-10-01)

Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability
by: E. V. Grakova, et al.
Published: (2023-07-01)

Modern aspects of angina treatment in arterial hypertension patients: emphasizing endothelial function role
by: L. L. Kirichenko, et al.
Published: (2008-04-01)

How much should the resting heart rate be controlled in patients with atrial fibrillation and coronary heart disease?
by: Yan-bo Wang, et al.
Published: (2024-11-01)

IF CHANNEL INHIBITOR IVABRADINE AND CHRONIC HEART FAILURE MANAGEMENT: FROM DISCUSSION TO ACTION
by: Yu. M. Lopatin
Published: (2012-08-01)

The myocardial remodeling at ischemic chronic heart failure: the features of Ivabradine influence in experimental model
by: S. V. Fedorov, et al.
Published: (2016-12-01)

Episodes of acute heart rate variability decrease in coronary heart disease patients and healthy people at normal levels of physical stress
by: E. Ya. Parnes, et al.
Published: (2005-06-01)

Heart rate variability during orthostatic test, and central hemodynamic parameters in coronary heart disease patients with arterial hypertension
by: A. D. Ibatov
Published: (2004-02-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)

The effect of ivabradine as part of standard therapy on vascular endothelial function and cardiac electrical instability in patients with post-infarction cardiosclerosis and heart failure
by: A. A. Abdullaev, et al.
Published: (2020-02-01)

HEART RATE VARIABILITY IN ASSESSMENT OF CLINICAL STATUS, FUNCTIONAL CONDITIONS AND PROGNOSIS IN HEART FAILURE
by: Y. A. Vasyuk, et al.
Published: (2016-01-01)

Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention
by: K. A. Nazarova, et al.
Published: (1970-01-01)

Heart rate variability in patients with chronic rheumatic heart disease
by: V. S. Petrov
Published: (2019-11-01)

ANTIISCHEMIC EFFECTIVENESS OF IVABRADINE AND ITS IMPACT ON MICROCIRCULATION IN PATIENTS WITH CORONARY HEART DISEASE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. A. Garganeeva, et al.
Published: (2012-08-01)

EARLY DIAGNOSTICS OF HEART FAILURE IN PATIENTS WITH CORONARY HEART DISEASE
by: O. V. Bulashova, et al.
Published: (2003-08-01)

Individual dynamics of heart rate variability in treated cardiac patients
by: E. Ya. Parnes
Published: (2009-10-01)

Combination of coronary heart disease, chronic heart failure, and anaemic syndrome: clinical features and prognostic impact of anaemia treatment
by: T. Yu. Kalyuta, et al.
Published: (2013-04-01)

STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE IN PATIENTS WITH HEART FAILURE, CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. PASHCHENKO, et al.
Published: (2018-10-01)

MODULATED KINESIOTHERAPY IN PATIENTS WITH COMPLICATED CORONARY HEART DISEASE
by: A. I. Olesin, et al.
Published: (2012-04-01)

Could secondary prevention of coronary heart disease be more effective?
by: V. I. Makolkin
Published: (2010-02-01)

MYOCARDIUM REPOLARIZATION PARAMETERS AND HEART RATE VARIABILITY IN PATIENTS WITH COMBINED CORONARY HEART DISEASE AND GASTROESOPHAGEAL REFLUX DISEASE
by: S. V. Loginov, et al.
Published: (2003-10-01)

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

Diuretic therapy effects on the signal-averaged ECG parameters of atrial complex and supraventricular arrhythmias in patients with coronary heart disease and chronic heart failure
by: Kh. Kh. Shugushev, et al.
Published: (2011-12-01)